FDG positron emission tomography in isolated limb perfusion therapy in patients with locally advanced melanoma: Preliminary results

Clinical Nuclear Medicine

Volumn 26, Issue 10, 2001, Pages 832-836

  Mercier, Gustavo A ^a   Alavi, Abass ^a,b   Fraker, Douglas L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

F 18 Fluorodeoxyglucose; Isolated Limb Perfusion; Melanoma; Positron Emission Tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MELPHALAN; TUMOR NECROSIS FACTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIMB PERFUSION; MALE; MEDIASTINUM LYMPH NODE; MELANOMA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DRUG THERAPY, COMBINATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIKELIHOOD FUNCTIONS; MALE; MELANOMA; MELPHALAN; MIDDLE AGED; NEOPLASM METASTASIS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR NECROSIS FACTOR-ALPHA; WHOLE-BODY COUNTING;

EID: 0034814864     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200110000-00005     Document Type: Article

References (11)

1. Clinical management and current research in isolated limb perfusion for sarcoma and melanoma
2. Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography
3. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose
4. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma
5. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxy-glucose positron emission tomography
6. Malignant melanoma: Staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose
7. Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma
8. The use of tumour necrosis factor (TNF) in isolated perfusion: Results and side effects. The NCI results
9. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma
10. Standards for performance measurements of PET scanners: Evaluation with the UGM PENN-PET 240H scanner
11. Improved image quality of whole-body FDG-PET scans by employing a practical algorithm: Expectation maximization with ordered subsets (EMOS)